Stockscreener 앱 받기
3.77
4.31%
-0.17
전일 마감가:
$3.94
열려 있는:
$3.93
하루 거래량:
6.98M
Relative Volume:
1.94
시가총액:
$420.74M
수익:
$2.35B
순이익/손실:
$-74.42M
주가수익비율:
-4.0106
EPS:
-0.94
순현금흐름:
$150.93M
1주 성능:
-9.59%
1개월 성능:
-7.37%
6개월 성능:
-67.05%
1년 성능:
-62.89%
1일 변동 폭
$3.71
$3.966
1주일 범위
$3.71
$4.20
52주 변동 폭
$3.495
$12.06
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.77 | 439.71M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Aug Outlook: How sensitive is Evolent Health Inc to inflationJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
Shorts Report: Whats next for Evolent Health Inc stock2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
Market Wrap: Will Alvotech benefit from government policyJuly 2025 Reactions & Verified Entry Point Detection - baoquankhu1.vn
Signal Recap: Is now the right time to enter Evolent Health IncJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
Evolent Health (EVH) Price Target Decreased by 10.18% to 9.33 - Nasdaq
Market Fear: How Evolent Health Inc stock valuations compare to rivalsWeekly Trend Recap & Daily Profit Maximizing Tips - Bộ Nội Vụ
Loss Report: Will Evolent Health Inc stock recover faster than marketDividend Hike & Advanced Swing Trade Entry Alerts - Bộ Nội Vụ
Evolent Health, Inc. (EVH) Stock Analysis: A 131% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews
(EVH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Evolent Health (EVH) Q1 Earnings Lag Estimates - sharewise.com
Does Evolent Health Inc. stock trade at a discount to peersQuarterly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
How Evolent Health Inc. stock reacts to inflationary pressures2025 Volatility Report & Step-by-Step Swing Trade Plans - Улправда
Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth - MSN
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Citigroup Lowers Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Aug Wrap: How Evolent Health Inc. stock reacts to bond yieldsTrend Reversal & Long-Term Growth Portfolio Plans - Улправда
Quarterly Earnings: How Evolent Health Inc stock reacts to job market dataQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Bộ Nội Vụ
Entry Recap: How Evolent Health Inc. stock reacts to job market dataMarket Volume Report & Technical Pattern Recognition Alerts - Улправда
Setup Watch: How Evolent Health Inc. stock reacts to inflationary pressures2025 Investor Takeaways & Fast Gain Swing Alerts - ulpravda.ru
How sustainable is Evolent Health Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
How Evolent Health Inc. stock reacts to bond yieldsCPI Data & Fast Entry Momentum Trade Alerts - Улправда
How Evolent Health Inc. stock reacts to job market dataPortfolio Growth Summary & High Conviction Trade Alerts - ulpravda.ru
Insider Stock Buying Reaches US$1.38m On Evolent Health - Yahoo Finance
Is the options market predicting a spike in Evolent Health stock? - MSN
Evolent Health (EVH) Analyst Maintains Rating, Lowers Price Targ - GuruFocus
Evolent Health, Inc. (EVH) Stock Analysis: Can a 155% Upside Propel This Healthcare Innovator? - DirectorsTalk Interviews
Citizens lowers Evolent Health stock price target on ACA membership concerns - Investing.com Canada
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Evolent reports inducement award - Medical Buyer
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - The Malaysian Reserve
Evolent Health Appoints New CFO Mario Ramos with $2.35M Stock Award - Intellectia AI
Evolent reports inducement award under NYSE listing rule 303A.08 - MarketScreener
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 – Company Announcement - Financial Times
To recruit its new finance chief, Evolent puts $2.35M in stock on the table - Stock Titan
The Truth About Evolent Health Inc (EVH): Underdog Stock or Next Big Health Tech Flex? - AD HOC NEWS
Evolent Health, Inc. (EVH) Stock Analysis: Evaluating A Promising 150% Potential Upside - DirectorsTalk Interviews
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - Quantisnow
Is the Options Market Predicting a Spike in Evolent Health Stock? - Zacks Investment Research
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Would You Still Hold Evolent Health Stock If It Fell 30%? - Trefis
Evolent Health (EVH) downgraded by Canaccord amid increased near-term uncertainty and ambiguity in Medicare/Medicaid membership - MSN
Energy Moves: Why Evolent Health Inc stock is trending among retail tradersPortfolio Update Summary & Trade Opportunity Analysis Reports - moha.gov.vn
How Evolent Health Inc Class stock compares with tech leaders2025 Short Interest & Daily Entry Point Alerts - Улправда
Why Evolent Health Inc. stock is trending among retail tradersWeekly Market Outlook & Free Community Consensus Stock Picks - DonanımHaber
How Evolent Health Inc Class stock reacts to Fed tighteningJuly 2025 Closing Moves & Trade Opportunity Analysis - DonanımHaber
Can Evolent Health Inc Class stock surprise with quarterly resultsJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Is Evolent Health Inc. stock a dividend growth opportunityJuly 2025 Reactions & Scalable Portfolio Growth Methods - Улправда
EVH (Evolent Health) Debt-to-Asset : 0.44 (As of Sep. 2025) - GuruFocus
Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership - Insider Monkey
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
2.88%
자본화:
|
볼륨(24시간):